Evidence map›Paper›PMID 18790831›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2008

Role of EDHF in type 2 diabetes-induced endothelial dysfunction.

Yoonjung Park, Stefano Capobianco, Xue Gao, John R Falck, Kevin C Dellsperger, Cuihua Zhang

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Restricted Intimal CaFrontiers in physiology · 2022
    Article
  9. Review
  10. Article
  11. Redox Signaling and Regional Heterogeneity of Endothelial Dysfunction inInternational journal of molecular sciences · 2020
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Regulation of Coronary Blood Flow.Comprehensive Physiology · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yoonjung ParkDepartment of Internal Medicine, Medical Pharmacology and Physiology and Nutritional Science, Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211, USA.
Stefano Capobianco
Xue Gao
John R Falck
Kevin C Dellsperger
Cuihua Zhang
University of Missouri · US

Funding

Role of Cytokine-Induced Inflammation in Endothelial Dysfunction in DiabetesR01HL085119 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI HILL, MICHAEL A · 2007 to 2015
$3.1M
Mechanisms of Reperfusion-induced Endothelial InjuryR01HL077566 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI HILL, MICHAEL A · 2006 to 2010
$1.8M
NHLBI NIH HHS R01-HL-077566NHLBI NIH HHS R01-HL-085119
6 · The paper itself

Abstract

Endothelium-derived hyperpolarizing factor (EDHF) plays a crucial role in modulating vasomotor tone, especially in microvessels when nitric oxide-dependent control is compromised such as in diabetes. Epoxyeicosatrienoic acids (EETs), potassium ions (K+), and hydrogen peroxide (H2O2) are proposed as EDHFs. However, the identity (or identities) of EDHF-dependent endothelial dilators has not been clearly elucidated in diabetes. We assessed the mechanisms of EDHF-induced vasodilation in wild-type (WT, normal), db/db (advanced type 2 diabetic) mice, and db/db mice null for TNF (dbTNF-/dbTNF-). In db/db mice, EDHF-induced vasodilation [ACh-induced vasodilation in the presence of N(G)-nitro-L-arginine methyl ester (L-NAME, 10 micromol/l) and prostaglandin synthase inhibitor indomethacin (Indo, 10 mumol/l)] was diminished after the administration of catalase (an enzyme that selectively dismutates H2O2 to water and oxygen, 1,000 U/ml); administration of the combination of charybdotoxin (a nonselective blocker of intermediate-conductance Ca2+-activated K+ channels, 10 micromol/l) and apamin (a selective blocker of small-conductance Ca2+-activated K+ channels, 50 micromol/l) also attenuated EDHF-induced vasodilation, but the inhibition of EETs synthesis [14,15-epoxyeicosa-5(Z)-enoic acid; 10 mumol/l] did not alter EDHF-induced vasodilation. In WT controls, EDHF-dependent vasodilation was significantly diminished after an inhibition of K+ channel, EETs synthesis, or H2O2 production. Our molecular results indicate that mRNA and protein expression of interleukin-6 (IL-6) were greater in db/db versus WT and dbTNF-/dbTNF- mice, but neutralizing antibody to IL-6 (anti-IL-6; 0.28 mg.ml(-1).kg(-1) ip for 3 days) attenuated IL-6 expression in db/db mice. The incubation of the microvessels with IL-6 (5 ng/ml) induced endothelial dysfunction in the presence of l-NAME and Indo in WT mice, but anti-IL-6 restored ACh-induced vasodilation in the presence of L-NAME and Indo in db/db mice. In db(TNF-)/db(TNF-) mice, EDHF-induced vasodilation was greater and comparable with controls, but IL-6 decreased EDHF-mediated vasodilation. Our results indicate that EDHF compensates for diminished NO-dependent dilation in IL-6-induced endothelial dysfunction by the activation of H2O2 or a K+ channel in type 2 diabetes.

Indexed as

VasodilationAnimalsArteriolesBiological FactorsBlood GlucoseBody WeightCoronary VesselsCyclooxygenase InhibitorsDiabetes Mellitus, Type 2Disease Models, AnimalDose-Response Relationship, DrugEndothelium, VascularFemaleHydrogen PeroxideInterleukin-6MaleBiological FactorsBlood GlucoseCyclooxygenase Inhibitorsendothelium-dependent hyperpolarization factorHydrogen PeroxideInterleukin-6Nitric OxideNitric Oxide SynthasePotassium Channel BlockersPotassium ChannelsRNA, MessengerTumor Necrosis Factor-alphaVasodilator Agents

Identifiers

PMID18790831
PMCPMC2614585
OpenAlexW2155321653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.